info@birdgroup.be

Login

Papers

Clinical Gastroenterology and Hepatology, 2020 Jul; 18(8):1704-1718.
Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease

Journal of Crohn's and Colitis, Volume 14, Issue 5, May 2020, Pages 680–685,
Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases.

Clin Gastroenterol Hepatol. 2021 May;19(5):947-954.e2.
Infliximab Exposure Associates with Radiologic Evidence of Healing in Patients with Crohn's Disease.

Clin Gastroenterol Hepatol. 2021 Aug;19(8):1573-1582.e5.
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.

Am J Gastroenterol. 2021 Jan 1;116(1):134-141.
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.

Frontiers in Pediatrics, 05 February 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus.

Inflammatory Bowel Diseases, izab042.
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.

Inflammatory Bowel Diseases, izab143.
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.

‹
1
2
3
4
5
6
7
›